Correlation Between CTT Pharmaceutical and Brainsway

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTT Pharmaceutical and Brainsway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTT Pharmaceutical and Brainsway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTT Pharmaceutical Holdings and Brainsway, you can compare the effects of market volatilities on CTT Pharmaceutical and Brainsway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTT Pharmaceutical with a short position of Brainsway. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTT Pharmaceutical and Brainsway.

Diversification Opportunities for CTT Pharmaceutical and Brainsway

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between CTT and Brainsway is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding CTT Pharmaceutical Holdings and Brainsway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainsway and CTT Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTT Pharmaceutical Holdings are associated (or correlated) with Brainsway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainsway has no effect on the direction of CTT Pharmaceutical i.e., CTT Pharmaceutical and Brainsway go up and down completely randomly.

Pair Corralation between CTT Pharmaceutical and Brainsway

Given the investment horizon of 90 days CTT Pharmaceutical Holdings is expected to generate 1.68 times more return on investment than Brainsway. However, CTT Pharmaceutical is 1.68 times more volatile than Brainsway. It trades about 0.04 of its potential returns per unit of risk. Brainsway is currently generating about -0.04 per unit of risk. If you would invest  6.90  in CTT Pharmaceutical Holdings on September 3, 2024 and sell it today you would earn a total of  0.09  from holding CTT Pharmaceutical Holdings or generate 1.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

CTT Pharmaceutical Holdings  vs.  Brainsway

 Performance 
       Timeline  
CTT Pharmaceutical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Brainsway 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Brainsway showed solid returns over the last few months and may actually be approaching a breakup point.

CTT Pharmaceutical and Brainsway Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTT Pharmaceutical and Brainsway

The main advantage of trading using opposite CTT Pharmaceutical and Brainsway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTT Pharmaceutical position performs unexpectedly, Brainsway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will offset losses from the drop in Brainsway's long position.
The idea behind CTT Pharmaceutical Holdings and Brainsway pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing